Feasibility and impact of an evidence-based electronic decision support system for diabetes care in family medicine: protocol for a cluster randomized controlled trial

Implement Sci. 2013 Aug 5:8:83. doi: 10.1186/1748-5908-8-83.

Abstract

Background: In Belgium, the construction of the national electronic point-of-care information service, EBMPracticeNet, was initiated in 2011 to optimize quality of care by promoting evidence-based decision-making. The collaboration of the government, healthcare providers, Evidence-Based Medicine (EBM) partners, and vendors of Electronic Health Records (EHR) is unique to this project. All Belgian healthcare professionals get free access to an up-to-date database of validated Belgian and nearly 1,000 international guidelines, incorporated in a portal that also provides EBM information from sources other than guidelines, including computerized clinical decision support that is integrated in the EHRs.

Methods: The study is a cluster-randomized trial with before/after measurements conducted in Belgian family medicine. Physicians' practices will be randomly assigned to the intervention or control group in a 1:1 ratio, to receive either the EBMeDS reminders or to follow the usual care process. Randomization will be performed by a statistical consultant with an electronic random list generator, anonymously for the researchers. The follow-up period of the study will be 12 months with interim analysis points at 3, 6 and 9 months. Primary outcome is the one-year pre- to post-implementation change in HbA1c. Patients will not be informed about the intervention. Data analysts will be kept blinded to the allocation.

Discussion: The knowledge obtained in this study will be useful for further integration in other Belgian software packages. Users' perceptions and process evaluation will provide information for improving the feasibility of the system.

Trial registration: The trial is registered with the ClinicalTrials.gov registry: NCT01830569.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Belgium
  • Blood Pressure / physiology
  • Cholesterol / blood
  • Decision Support Systems, Clinical*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / therapy*
  • Electronic Health Records*
  • Evidence-Based Medicine
  • Family Practice
  • Feasibility Studies
  • Glycated Hemoglobin / analysis
  • Humans

Substances

  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human
  • Cholesterol

Associated data

  • ClinicalTrials.gov/NCT01830569